Cancer Statistics, 2017 | Ca-A Cancer Journal for Clinicians | 2017 | 12K |
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association | Circulation | 2017 | 5.6K |
A survey on deep learning in medical image analysis | Medical Image Analysis | 2017 | 4.9K |
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease | New England Journal of Medicine | 2017 | 3.9K |
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes | New England Journal of Medicine | 2017 | 3.8K |
Introducing EzBioCloud: a taxonomically united database of 16S rRNA gene sequences and whole-genome assemblies | International Journal of Systematic and Evolutionary Microbiology | 2017 | 3.6K |
2017 ESC/EACTS Guidelines for the management of valvular heart disease | European Heart Journal | 2017 | 3.6K |
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 | Lancet, The | 2017 | 3.4K |
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 | Intensive Care Medicine | 2017 | 3.2K |
Health Effects of Overweight and Obesity in 195 Countries over 25 Years | New England Journal of Medicine | 2017 | 3K |
Cancer nanomedicine: progress, challenges and opportunities | Nature Reviews Cancer | 2017 | 3K |
Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults | Lancet, The | 2017 | 3K |
Canu: scalable and accurate long-read assembly via adaptive -mer weighting and repeat separation | Genome Research | 2017 | 2.9K |
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel | Blood | 2017 | 2.8K |
Dementia prevention, intervention, and care | Lancet, The | 2017 | 2.8K |
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease | New England Journal of Medicine | 2017 | 2.7K |
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial | Lancet, The | 2017 | 2.7K |
Estimates and 25-year trends of the global burden of disease attributable to ambient air pollution: an analysis of data from the Global Burden of Diseases Study 2015 | Lancet, The | 2017 | 2.7K |
Colorectal cancer statistics, 2017 | Ca-A Cancer Journal for Clinicians | 2017 | 2.6K |
Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016 | Lancet, The | 2017 | 2.5K |
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases | Nature Reviews Drug Discovery | 2017 | 2.4K |
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study | JAMA Oncology | 2017 | 2.4K |
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection | Journal of Hepatology | 2017 | 2.4K |
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma | New England Journal of Medicine | 2017 | 2.3K |
Global patterns and trends in colorectal cancer incidence and mortality | Gut | 2017 | 2.3K |